249 related articles for article (PubMed ID: 24677539)
1. Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder.
Satpathy AT; Briseño CG; Cai X; Michael DG; Chou C; Hsiung S; Bhattacharya D; Speck NA; Egawa T
Blood; 2014 May; 123(19):2968-77. PubMed ID: 24677539
[TBL] [Abstract][Full Text] [Related]
2. Runx1-Cbfβ facilitates early B lymphocyte development by regulating expression of Ebf1.
Seo W; Ikawa T; Kawamoto H; Taniuchi I
J Exp Med; 2012 Jul; 209(7):1255-62. PubMed ID: 22665574
[TBL] [Abstract][Full Text] [Related]
3. A RUNX-CBFβ-driven enhancer directs the Irf8 dose-dependent lineage choice between DCs and monocytes.
Murakami K; Sasaki H; Nishiyama A; Kurotaki D; Kawase W; Ban T; Nakabayashi J; Kanzaki S; Sekita Y; Nakajima H; Ozato K; Kimura T; Tamura T
Nat Immunol; 2021 Mar; 22(3):301-311. PubMed ID: 33603226
[TBL] [Abstract][Full Text] [Related]
4. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
Miller JD; Stacy T; Liu PP; Speck NA
Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewal.
Zhao X; Chen A; Yan X; Zhang Y; He F; Hayashi Y; Dong Y; Rao Y; Li B; Conway RM; Maiques-Diaz A; Elf SE; Huang N; Zuber J; Xiao Z; Tse W; Tenen DG; Wang Q; Chen W; Mulloy JC; Nimer SD; Huang G
Blood; 2014 Mar; 123(11):1729-38. PubMed ID: 24449215
[TBL] [Abstract][Full Text] [Related]
6. Essential functions of Runx/Cbfβ in gut conventional dendritic cells for priming Rorγt
Tenno M; Wong AYW; Ikegaya M; Miyauchi E; Seo W; See P; Kato T; Taida T; Ohno-Oishi M; Ohno H; Yoshida H; Ginhoux F; Taniuchi I
Life Sci Alliance; 2020 Jan; 3(1):. PubMed ID: 31818882
[TBL] [Abstract][Full Text] [Related]
7. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11.
Kundu M; Chen A; Anderson S; Kirby M; Xu L; Castilla LH; Bodine D; Liu PP
Blood; 2002 Oct; 100(7):2449-56. PubMed ID: 12239155
[TBL] [Abstract][Full Text] [Related]
8. Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and RelB
Elizondo DM; Brandy NZD; da Silva RLL; Haddock NL; Kacsinta AD; de Moura TR; Lipscomb MW
Front Immunol; 2019; 10():173. PubMed ID: 30800127
[TBL] [Abstract][Full Text] [Related]
9. Genetic evidence of PEBP2beta-independent activation of Runx1 in the murine embryo.
Yokomizo T; Yanagida M; Huang G; Osato M; Honda C; Ema M; Takahashi S; Yamamoto M; Ito Y
Int J Hematol; 2008 Sep; 88(2):134-138. PubMed ID: 18594778
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1.
Won H; Nandakumar V; Yates P; Sanchez S; Jones L; Huang XF; Chen SY
Blood; 2014 Oct; 124(17):2647-56. PubMed ID: 25217698
[TBL] [Abstract][Full Text] [Related]
11. IRF8 acts in lineage-committed rather than oligopotent progenitors to control neutrophil vs monocyte production.
Yáñez A; Ng MY; Hassanzadeh-Kiabi N; Goodridge HS
Blood; 2015 Feb; 125(9):1452-9. PubMed ID: 25597637
[TBL] [Abstract][Full Text] [Related]
12. RUNX1 and CBFβ-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development.
Zhen T; Cao Y; Ren G; Zhao L; Hyde RK; Lopez G; Feng D; Alemu L; Zhao K; Liu PP
Blood; 2020 Nov; 136(21):2373-2385. PubMed ID: 32929473
[TBL] [Abstract][Full Text] [Related]
13. Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice.
Hyde RK; Zhao L; Alemu L; Liu PP
Leukemia; 2015 Aug; 29(8):1771-8. PubMed ID: 25742748
[TBL] [Abstract][Full Text] [Related]
14. Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.
Chan G; Kalaitzidis D; Usenko T; Kutok JL; Yang W; Mohi MG; Neel BG
Blood; 2009 Apr; 113(18):4414-24. PubMed ID: 19179468
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell development requires histone deacetylase activity.
Chauvistré H; Küstermann C; Rehage N; Klisch T; Mitzka S; Felker P; Rose-John S; Zenke M; Seré KM
Eur J Immunol; 2014 Aug; 44(8):2478-88. PubMed ID: 24810486
[TBL] [Abstract][Full Text] [Related]
16. Core Binding Factor-β Knockdown Alters Ovarian Gene Expression and Function in the Mouse.
Wilson K; Park J; Curry TE; Mishra B; Gossen J; Taniuchi I; Jo M
Mol Endocrinol; 2016 Jul; 30(7):733-47. PubMed ID: 27176614
[TBL] [Abstract][Full Text] [Related]
17. RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation.
Cammenga J; Niebuhr B; Horn S; Bergholz U; Putz G; Buchholz F; Löhler J; Stocking C
Cancer Res; 2007 Jan; 67(2):537-45. PubMed ID: 17234761
[TBL] [Abstract][Full Text] [Related]
18. Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11.
Hyde RK; Kamikubo Y; Anderson S; Kirby M; Alemu L; Zhao L; Liu PP
Blood; 2010 Feb; 115(7):1433-43. PubMed ID: 20007544
[TBL] [Abstract][Full Text] [Related]
19. Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to
Porter SN; Cluster AS; Yang W; Busken KA; Patel RM; Ryoo J; Magee JA
Elife; 2016 Nov; 5():. PubMed ID: 27879203
[TBL] [Abstract][Full Text] [Related]
20. CBFβ and RUNX1 are required at 2 different steps during the development of hematopoietic stem cells in zebrafish.
Bresciani E; Carrington B; Wincovitch S; Jones M; Gore AV; Weinstein BM; Sood R; Liu PP
Blood; 2014 Jul; 124(1):70-8. PubMed ID: 24850758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]